Advertisement

Topics

US FDA rejects Pfizer's Epogen biosimilar citing McPherson site warning

09:42 EDT 23 Jun 2017 | BioPharma-Reporter

Original Article: US FDA rejects Pfizer's Epogen biosimilar citing McPherson site warning

NEXT ARTICLE

More From BioPortfolio on "US FDA rejects Pfizer's Epogen biosimilar citing McPherson site warning"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...